CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network) Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention The Wait for High-Sensitivity Troponin Is Over—Proceed Cautiously Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes

Original Research2020 Nov 21;ehaa874.

JOURNAL:Eur Heart J. Article Link

Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study

M Fedchenko, Z Mandalenakis, KW Giang et al. Keywords: congenital heart disease; post AMI; outcome

Full Text PDF

网站资料更新中...